
The study discovered a potential link between the development of bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH) in premature infants. The study focuses on the role of nitric oxide (NO) and an enzyme called dimethylarginine dimethylaminohydrolase-1 (DDAH1) in this process. By manipulating DDAH1 levels in human lung cells, the study observed that lower DDAH1 resulted in reduced NO production, decreased apoptosis (cell death), and increased proliferation of smooth muscle cells in the pulmonary arteries. These findings shed light on potential targets for preventing abnormal pulmonary vascular growth in BPD-PH.
Like
Save
Share